Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Fagron NV

ARSUFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$27.00
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Fagron NV (ARSUF) Stock Overview

Explore Fagron NV’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio18.40
EPS (TTM)$1.38
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$26.05
3 Months$25.44
1 Year Target$26.99

ARSUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Fagron NV (ARSUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.40 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.71%
3-Month Change
14.89%
6-Month Change
7.14%
Year-to-Date (YTD) Change
14.89%
1-Year Change
34.80%
3-Year Change
100.00%
5-Year Change
10.47%
All-Time (Max) Change
-50.52%

Contact Information

32 8 001 28 80
Venecoweg 20A, Nazareth, NaN, 9810

Company Facts

38,280 Employees
IPO DateFeb 21, 2017
CountryBE
Actively Trading

Frequently Asked Questions